Healthcare, Pharmaceuticals and Biotech

See All Insights See All Insights

See All Events See All Events

Kroll Life Sciences Webcast Series

Pharmaceutical, healthcare, biotech and medical device companies face a challenging, competitive health landscape. Pricing pressures, scientific breakthroughs, expanding demand for healthcare access and emerging digital and analytic capabilities push companies to explore unconventional business models and build value-based customer relationships. Kroll recently brought together our leading experts and industry leaders to share insights and trends on valuation, technology, intellectual property (IP), risk and regulation in a life sciences webcast series.

Watch Webcast Replays Watch Webcast Replays

People

Kroll helps organizations in the healthcare, pharmaceuticals and biotechnology sectors address complex business challenges related to governance, risk and transparency.

Pharmaceutical, healthcare, biotech and medical device companies face a challenging, competitive health landscape. Pricing pressures, scientific breakthroughs, expanding demand for healthcare access and emerging digital and analytic capabilities push companies to explore unconventional business models and build value-based customer relationships.

Underpinning these dynamics is the uncertainty created by a post-COVID-19 environment. The implications have been far-reaching and will likely impact the entire life science ecosystem. While companies need to be aware of the risks to their organization, Kroll understands the complexity of these challenges and works with clients worldwide to drive progress, navigate new opportunities and manage risk.

Our life sciences specialists bring practical, in-depth experience to healthcare and life sciences companies, including consumer health, medical devices, diagnostics and pharmaceuticals. We help our clients address their most pressing challenges in in the areas of valuation, expert services, investigations, cyber risk, corporate finance, security, restructuring, legal and business solutions, data analytics, due diligence and regulatory compliance.

Please join us June 21-24 for Kroll’s Life Sciences week. We will bring together our leading experts and industry leaders to set the roadmap for a new era where pharma, patients, providers and society are united in their efforts of greater value.

We will provide insights for pharmaceutical and life sciences professionals on operational risk, compliance, supply chain, health and safety and technology, including:

  • “Deep-dive interviews” with industry leaders demonstrating examples on their approach
  • Inherent  risks impacting the industry   
  • Case studies on how the life science industry has managed to adapt to market changes
  • Commentary on the latest regulation, technology developments and industry trends
  • Panel discussions that cover the most important challenges due to the impact of COVID-19


Other Areas We Can Help

Valuation Advisory

Valuation Advisory

Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.

Valuation Advisory
Healthcare M&A Advisory

Healthcare MA

Healthcare expertise for middle-market M&A transactions.

Healthcare MA
Transaction Advisory Services

Transaction Advisory Services

Seamless analytical advisory through the deal continuum, from transaction origination to closing.

Transaction Advisory Services
Tax Services

Tax Services

Built upon the foundation of its renowned valuation business, Duff & Phelps' Tax Services practice follows a detailed and responsive approach to capturing value for clients.

Tax Services
Cyber Risk

Cyber Risk

Global, end-to-end cyber risk solutions.

Cyber Risk
Security Risk Management

Security Risk Management

Helping clients anticipate/respond to a myriad of facility, operational and employee security challenges.

Security Risk Management
Expert Services

Expert Services

Independent expert analysis, testimony, advice and investigations for complex disputes and projects.

Expert Services

Events

New Trends Identified – Kroll's 2021 Anti-Bribery and Corruption Benchmarking Report

Calendar

Location

Kroll Alternative Investments Virtual Conference

Calendar

Location

Insights

Episode 3

Protection of Vaccine Supply Chain

Episode 3

News